Biologics may have a beneficial effect in asthma patients with COVID-19
- PMID: 34244322
- PMCID: PMC8287737
- DOI: 10.1183/13993003.01076-2021
Biologics may have a beneficial effect in asthma patients with COVID-19
Abstract
Biologics may have a beneficial effect in asthma patients with COVID-19
Conflict of interest statement
Conflict of interest: J.L. Izquierdo reports personal fees from AstraZeneca, Bayer, Boehringer Ingelheim, Chiesi, GSK, Grifols, Menarini, Novartis, Orion, Pfizer, Sandoz and Teva. Conflict of interest: J.B. Soriano has nothing to disclose.
Comment on
-
The impact of COVID-19 on patients with asthma.Eur Respir J. 2021 Mar 4;57(3):2003142. doi: 10.1183/13993003.03142-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33154029 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous